Evelina Mochnacova
Kosice, KI, Slovakia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Anti-SARS-CoV-2 VHH and C7C peptide fused with Angiopep-2 efficiently traverse blood-brain barrier model and neutralizes virus.
Journal: Frontiers in microbiology
Published: March 11, 2026
Differential transcriptome response of blood brain barrier spheroids to neuroinvasive Neisseria and Borrelia.
Journal: Frontiers in cellular and infection microbiology
Published: October 23, 2023
Signaling events evoked by domain III of envelop glycoprotein of tick-borne encephalitis virus and West Nile virus in human brain microvascular endothelial cells.
Journal: Scientific reports
Published: January 31, 2022
Engineering the Single Domain Antibodies Targeting Receptor Binding Motifs Within the Domain III of West Nile Virus Envelope Glycoprotein.
Journal: Frontiers in microbiology
Published: October 25, 2021
Simple and rapid pipeline for the production of cyclic and linear small-sized peptides in E. coli.
Journal: Protein expression and purification
Published: August 26, 2021
Comprehensive Mapping of the Cell Response to Borrelia bavariensis in the Brain Microvascular Endothelial Cells in vitro Using RNA-Seq.
Journal: Frontiers in microbiology
Published: August 18, 2021
Development of peptides targeting receptor binding site of the envelope glycoprotein to contain the West Nile virus infection.
Journal: Scientific reports
Published: May 17, 2021
Single Domain Antibodies Targeting Receptor Binding Pockets of NadA Restrain Adhesion of Neisseria meningitidis to Human Brain Microvascular Endothelial Cells.
Journal: Frontiers in molecular biosciences
Published: June 16, 2020
Transcriptomic analysis of human brain microvascular endothelial cells exposed to laminin binding protein (adhesion lipoprotein) and Streptococcus pneumoniae.
Journal: Scientific reports
Published: February 07, 2020
Comprehensive mapping of the cell response to E. coli infection in porcine intestinal epithelial cells pretreated with exopolysaccharide derived from Lactobacillus reuteri.
Journal: Veterinary research
Published: December 09, 2019
Last Updated: 09/26/2026